Tristel plc
("Tristel" or the
"Company")
Exercise of Share Options and
Total Voting Rights
Tristel plc (AIM: TSTL), the
manufacturer of infection prevention products, announces that it
has issued and allotted a total of 60,500 new ordinary shares of 1
penny each in the capital of the Company ("Ordinary Shares")
following the exercise of options by employees of the
Group.
Application has been made to the
London Stock Exchange for the 60,500 new Ordinary Shares to be
admitted to trading on AIM ("Admission") and it is expected that
Admission will become effective and trading will commence at 8.00
a.m. on 13 August 2024.
Total Voting Rights
After Admission, the total number of
Ordinary Shares in issue will be 47,614,993 and the total number of
voting rights will therefore be 47,614,993. This figure may be used
by shareholders as the denominator for the calculations by which
they will determine if they are required to notify their interest
in, or a change to their interest in, the share capital of the
Company under the FCA's Disclosure Guidance and Transparency
Rules.
For further
information please contact:
Tristel plc
|
Via
Walbrook PR
|
Paul Swinney, Chief Executive
Officer
|
www.investors.tristel.com
|
Liz Dixon, Chief Financial
Officer
|
|
|
|
Walbrook PR Ltd
|
Tel: 020
7933 8780 or tristel@walbrookpr.com
|
Paul McManus
|
Mob: 07980
541 893
|
Charlotte Edgar
|
Mob: 07884
664 686
|
|
|
Cavendish Capital Markets Limited
|
Tel: 020
7220 0500
|
Geoff Nash / Dan Hodkinson / Trisyia
Jamaludin (Corporate Finance)
|
|
Sunila de Silva (ECM)
|
|
|
| |
About Tristel
plc
Tristel plc is a global infection
prevention company focussed on the manufacture and supply of
products using its unique proprietary chlorine dioxide
(ClO2) chemistry. The Company is a market leader
in manual decontamination of medical devices, supplying
hospitals under the Tristel brand, and under the Cache brand
provides products for sporicidal surface disinfection, in a format
which is a sustainable alternative to commonly used pre-wetted
plastic wipes.
Tristel's head office and manufacturing
facility is located in Snailwell, near Cambridge, and operates
globally employing approximately 250 people across 14 subsidiaries
selling into 40 countries.
The Company has been listed on the London Stock
Exchange's AIM market since 2005 (AIM: TSTL).
For more information about Tristel's product
range please visit: https://tristel.com